Friday | 5 December, 2008
Australian Biotechnology News

Stories about: ONYX Pharmaceuticals

  • +

    Progen abandons PI-88 23/07/2008 14:43:49

    Massive share price plunge as Progen abandons lead compound trial
  • +

    Onyx falls behind in cancer drug race 26/10/2004 14:54:40

    Onyx Pharmaceuticals - which is developing one of the most promising new cancer therapies on the horizon - has said it will not file for US approval of its kidney cancer drug as soon as some investors had anticipated.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Sponsored Links